ROZEMA DAVID B has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are JENNEREX INC, KIRN DAVID and TAKEDA VACCINE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Agriculture | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Animal care | |
#5 | Sugars | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Peptides | |
#8 | Heterocyclic compounds | |
#9 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Rozema David B | 13 |
#2 | Wakefield Darren H | 9 |
#3 | Wolff Jon A | 7 |
#4 | Lewis David L | 7 |
#5 | Hoffmann Torsten | 4 |
#6 | Hagstrom James E | 4 |
#7 | Mohr Peter | 4 |
#8 | Hadwiger Philipp | 4 |
#9 | Blokhin Andrei V | 3 |
#10 | Ott Guenther | 3 |
Publication | Filing date | Title |
---|---|---|
US2012230938A1 | Polyconjugates for in vivo delivery of polynucleotides | |
US2012165393A1 | Peptide-based in vivo siRNA delivery system | |
US2008281074A1 | Compounds and methods for reversible modification of biologically active molecules | |
US2008281041A1 | Reversibly Masked Polymers | |
US2008132689A1 | Labile Linkage for Compound Delivery to a Cell | |
US2007036865A1 | Endosomolytic polymers | |
US8217015B2 | Endosomolytic polymers |